+
Neuland Reports Strong FY26 Revenue And Margin Gains
ECONOMY & POLICY

Neuland Reports Strong FY26 Revenue And Margin Gains

Neuland Laboratories Limited reported annual results for the year ended 31 March 2026, with total income of Rs. 20,531 mn and EBITDA of Rs. 6,034 mn. The company said Q4FY26 revenue stood at Rs. 7,887 mn while Q4 EBITDA was Rs. 3,194 mn, reflecting strong sequential performance. Management noted robust operating leverage and improved margins during the fourth quarter.

EBITDA margin for Q4FY26 was 40.5 per cent, up from 17.3 per cent a year earlier, representing an increase of 2316 basis points. Profit before tax for the quarter was Rs. 2,870 mn and profit after tax was Rs. 2,125 mn. Year-on-year Q4 income rose 134.9 per cent while EBITDA increased 448.6 per cent and profit after tax grew 666.3 per cent.

The chief executive officer and managing director said the company had ended FY26 on a strong note and that business visibility was good in the short to medium term, anchored by commercial and near-commercial molecules. He said the company would focus on execution discipline, customer satisfaction and protection of business fundamentals while laying the groundwork for growth beyond the immediate horizon. Investments in peptide manufacturing and a new research and development centre were reported to be proceeding according to plan and business development efforts were being aligned to attract projects that support high quality, sustainable growth.

The company scheduled a one-hour earnings call at 17:30 IST on Tuesday, 12 May 2026, and said the transcript would be uploaded to the corporate website in due course. Neuland was described as a cGMP manufacturer with over four decades of experience, more than 300 developed processes, about 100 APIs and around 1000 regulatory filings across major jurisdictions, supported by multiple global certifications.

Neuland Laboratories Limited reported annual results for the year ended 31 March 2026, with total income of Rs. 20,531 mn and EBITDA of Rs. 6,034 mn. The company said Q4FY26 revenue stood at Rs. 7,887 mn while Q4 EBITDA was Rs. 3,194 mn, reflecting strong sequential performance. Management noted robust operating leverage and improved margins during the fourth quarter. EBITDA margin for Q4FY26 was 40.5 per cent, up from 17.3 per cent a year earlier, representing an increase of 2316 basis points. Profit before tax for the quarter was Rs. 2,870 mn and profit after tax was Rs. 2,125 mn. Year-on-year Q4 income rose 134.9 per cent while EBITDA increased 448.6 per cent and profit after tax grew 666.3 per cent. The chief executive officer and managing director said the company had ended FY26 on a strong note and that business visibility was good in the short to medium term, anchored by commercial and near-commercial molecules. He said the company would focus on execution discipline, customer satisfaction and protection of business fundamentals while laying the groundwork for growth beyond the immediate horizon. Investments in peptide manufacturing and a new research and development centre were reported to be proceeding according to plan and business development efforts were being aligned to attract projects that support high quality, sustainable growth. The company scheduled a one-hour earnings call at 17:30 IST on Tuesday, 12 May 2026, and said the transcript would be uploaded to the corporate website in due course. Neuland was described as a cGMP manufacturer with over four decades of experience, more than 300 developed processes, about 100 APIs and around 1000 regulatory filings across major jurisdictions, supported by multiple global certifications.

Related Stories

Gold Stories

Next Story
Real Estate

Peninsula Land launches 19 luxury villas in Pune

Pune’s residential landscape is witnessing a shift as premium homebuyers increasingly seek larger spaces, privacy and independent living options beyond high-rise apartments. Addressing this demand, Peninsula Land Limited, part of the Ashok Piramal Group, has launched AshokVillas, an exclusive collection of 19 premium furnished villas in Gahunje, Pune.The development combines the independence of a standalone home with the convenience and security of a managed residential community. Designed around low-density horizontal living, AshokVillas offers residents private spaces while providing acces..

Next Story
Infrastructure Urban

MyBranch Expands South India Network with 16 Workspace Centres

MyBranch has expanded its South India presence with a 50,000 sq ft flexible workspace network comprising 16 centres across 14 cities in Andhra Pradesh, Karnataka, Tamil Nadu and Telangana.The expansion reflects growing demand for flexible office infrastructure as businesses establish regional teams, satellite offices and operations beyond traditional metropolitan markets. MyBranch’s network spans Bengaluru, Coimbatore, Guntur, Hanamkonda, Hubballi, Hyderabad, Madurai, Mangaluru, Rajahmundry, Salem, Tirupati, Vellore, Vijayawada and Visakhapatnam, with a large office space in Chennai also und..

Next Story
Building Material

Walplast Launches Moisture-Resistant Gypsum Plaster Solutions

Walplast Products Pvt. Ltd. has expanded its HomeSure GypEx portfolio with the launch of GypEx MoistShield and GypEx Gold, two gypsum plaster solutions designed to address moisture-prone applications and improve plastering efficiency.The new products have been developed in response to the growing demand for faster construction processes, improved material performance and consistent surface quality. The solutions aim to simplify interior plastering while addressing specific application requirements across construction environments.“Through HomeSure GypEx MoistShield and GypEx Gold, we are exp..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code